ATX-101 for reduction of submental fat

Bibliography

• Hatef DA, Koshy JC, Sandoval SE, et al. The submental fat compartment of the neck. Semin Plast Surg 2009;23(4):288-91
   Google Scholar
• Pilsl U, Anderhuber F. The chin and adjacent fat compartments. Dermatol Surg 2010;36(2):214-18
   Google Scholar
• Ross R, Janssen I. Is abdominal fat preferentially reduced in response to exercise-induced weight loss? Med Sci Sports Exerc 1999;31(11 Suppl):S568-72
   Google Scholar
• Wollina U, Goldman A, Berger U, et al. Esthetic and cosmetic dermatology. Dermatol Ther 2008;21(2):118-30
   Google Scholar
• Goldman A. Submental Nd:YAG laser-assisted liposuction. Lasers Surg Med 2006;38(3):181-4
   Google Scholar
• Fabi SG, Goldman MP. Retrospective evaluation of micro-focused ultrasound for lifting and tightening the face and neck. Dermatol Surg 2014;40(5):569-75
   PubMed Web of Science ®Google Scholar
• Rittes PG. The use of phosphatidylcholine for correction of localized fat deposits. Aesth Plast Surg 2003;27(4):315-18
   Google Scholar
• Rose PT, Morgan M. Histological changes associated with mesotherapy for fat dissolution. J Cosmet Laser Ther 2005;7(1):17-19
   PubMedGoogle Scholar
• Rotunda AM, Suzuki H, Moy RL, et al. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg 2004;30(7):1001-8
   PubMed Web of Science ®Google Scholar
• Rotunda AM, Kolodney MS. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg 2006;32(4):465-80
   PubMed Web of Science ®Google Scholar
• Greenwood J, Adu J, Davey AJ, et al. The effect of bile salts on the permeability and ultrastructure of the perfused, energy-depleted, rat blood-brain barrier. J Cerebral Blood Flow Metab 1991;11(4):644-54
   Google Scholar
• Yang L, Zhang H, Fawcett JP, et al. Effect of bile salts on the transport of morphine-6-glucuronide in rat brain endothelial cells. J Pharm Scie 2011;100(4):1516-24
   Google Scholar
• Lin Y, Lin H, Liu Z, et al. Improvement of a sample preparation method assisted by sodium deoxycholate for mass-spectrometry-based shotgun membrane proteomics. J Sep Sci 2014;37(22):3321-9
   Google Scholar
• Rodríguez V, Rivoira M, Marchionatti A, et al. Ursodeoxycholic and deoxycholic acids: a good and a bad bile acid for intestinal calcium absorption. Arch Biochem Biophys 2013;540(1-2):19-25
   Google Scholar
• Li H, Lee JH, Kim S, et al. Phosphatidylcholine induces apoptosis of 3T3-L1 adipocytes. J Biomed Sci 2011;18:91
   Google Scholar
• Klein SM, Schreml S, Nerlich M, et al. In vitro studies investigating the effect of subcutaneous phosphatidylcholine injections in the 3T3-L1 adipocyte model: lipolysis of lipid dissolution? Plast Reconstr Surg 2009;124(2):419-27
   Google Scholar
• Thuangtong R, Bentow JJ, Knopp K, et al. Tissue-selective effects of injected deoxycholate. Dermatol Surg 2010;36(6):899-908
   PubMed Web of Science ®Google Scholar
• Gupta A, Lobocki C, Singh S, et al. Actions and comparative efficacy of phosphatidylcholine formulation and isolated sodium deoxycholate for different cells types. Aesthet Plast Surg 2009;33(3):346-52
   Google Scholar
• Won TJ, Nam Y, Lee HS, et al. Injection of phosphatidylcholine and deoxycholic acid regulates gene expression of lipolysis-related factors, pro-inflammatory cytokines, and hormones on mouse fat tissue. Food Chem Toxicol 2013;60:263-8
   PubMed Web of Science ®Google Scholar
• Reeds DN, Mohammed S, Klein S, et al. Metabolic and structural effects of phosphatidylcholine and deoxycholate injections on subcutaneous fat: a randomized controlled trial. Aesthet Surg J 2013;33(3):400-8
   Google Scholar
• Chung SJ, Lee CH, Lee HS, et al. The role of phosphatidylcholine and deoxycholic acid in inflammation. Life Sci 2014;108(2):88-93
   Google Scholar
• Bechara FG, Skrygan M, Kreuter A, et al. Cytokine mRNA levels in human fat tissue after injection lipolysis with phosphatidylcholine and deoxycholate. Arch Dermatol Res 2008;300(8):455-9
   Google Scholar
• Hübner NF, Horch RE, Polykandriotis E, et al. A histopathologic and immunohistochemical study on liquefaction of human adipose tissue ex vivo. Ann Plast Surg 2014;38(5):976-84
   Google Scholar
• Schuller-Petrovic S, Wölkart G, Höfler G, et al. Tissue-toxic effects of phosphatidylcholine/deoxacholate after subcutaneous injection for fat dissolution in rats and a human volunteer. Dermatol Surg 2008;34(4):529-42
   Google Scholar
• Noh Y, Heo CH. The effect of phosphatidylcholine and deoxycholate compound injections to the localized adipose tissue: an experimental study with a murine model. Arch Plast Surg 2012;39(5):453-6
   Google Scholar
• Yagima Odo ME, Cucé LC, Odo LM, et al. Action of sodium deoxycholate on subcutaneous human tissue: local and systemic effects. Dermatol Surg 2007;33(2):178-88
   Google Scholar
• Bechara FG, Sand M, Hoffmann K, et al. Fat tissue after lipolysis of lipomas: a histopathological and immunohistochemical study. J Cutan Pathol 2007;34(7):552-7
   Google Scholar
• Bechara FG, Mannherz HG, Jacob M, et al. Induction of fat cell necrosis in human fat tissue after treatment with phosphatidylcholine and deoxycholate. J Eur Acad Dermatol Venereol 2012;26(2):180-5
   Google Scholar
• Park EJ, Kim HS, Kim M, et al. Histological changes after treatment for localized fat deposits with phosphatidylcholine and sodium deoxycholate. J Cosmet Dermatol 2013;12(3):240-3
   Google Scholar
• Jayasinghe S, Guillot T, Bissoon L, et al. Mesotherapy for local fat reduction. Obes Rev 2013;14(10):780-91
   Google Scholar
• Walker S. Treatment of submental fat. Available from: http://www.google.com/patents/WO2012112940A1?cl=en [Last accessed 21 December 2014]
   Google Scholar
• Clinical Trials. Available from: https://clinicaltrials.gov [Last accessed 20 December 2014]
   Google Scholar
• Walker P, Havlickova B, Lee D. ATX-101 for reduction of submental fat: pharmacokinetic and safety findings from a Phase I trial. Presented at 8th European Masters in Anti-Aging Medicine; 12-14 October 2012; Paris
   Google Scholar
• Goodman G, Smith K, Lee D, et al. ATX-101, a pharmacological treatment for the reduction of submental fat: results of two pooled Phase IIa studies. Presented at 21st Annual Congress of the European Academy of Dermatology and Venereology; 27-30 September 2012; Prague
   Google Scholar
• Young VL, Dover J, Schlessinger J, et al. A multicenter, randomized, double-blind Phase IIB study of ATX-101 in the reduction of submental fat using investigator, subject, and magnetic resonance imaging assessments. Presented at “The Aesthetic Meeting 2013”; 11-16 April 2013; New York. Available from: https://asapas.confex/asaps/2013/webprogra/Paper5753.html [ [Last accessed 10 December 2014]
   Google Scholar
• McDiarmid J, Ruiz JB, Lee D, et al. Results from a pooled analysis of two European, randomized, placebo-controlled, Phase III studies of ATX-101 for the pharmacologic reduction of excess submental fat. Aesthet Plast Surg 2014;38(5):849-60
   Google Scholar
• Rzany B, Griffiths T, Walker P, et al. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a Phase III, randomized, placebo-controlled study. Br J Dermatol 2014;170(2):445-53
   Google Scholar
• Ascher B, Hoffmann K, Walker P, et al. Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid). An injectable drug for the reduction of unwanted submental fat: results from a Phase III, randomized, placebo-controlled study. J Eur Acad Dermatol Venereol 2014;38(12):1707-15
   Google Scholar
• Dayan SH, Jones DH, Carrruthers J, et al. A pooled analysis of the safety and efficacy results of the multicenter, double-blind, randomized, placebo-controlled Phase III REFINE-1 and REFINE-2 trials of ATX-101, a submental contouring injectable drug for the reduction of submental fat. Plast Reconstr 2014;134(4 Suppl 1):123
   Google Scholar
• Bechara FG, Georgas D, Sand M, et al. Encapsulated fat necrosis after lipolysis of the calf with phosphatidylcholine. Dermatology 2008;216(2):180-1
   Google Scholar
• Pindur L, Sand M, Altmeyer P, et al. Recurrent growth of lipomas after previous treatment with phosphatidylcholine and deoxycholate. J Cosmet Laser Ther 2011;13(2):95-6
   Web of Science ®Google Scholar
• Salti G, Ghersetich I, Tanussi F, et al. Phosphatidylcholine and sodium deoxycholate in the treatment of localized fat: a double-blind, randomized study. Dermatol Surg 2008;34(1):60-6
   Google Scholar
• Rittes PG. Complications of Lipostabil Endovena for treating localized fat deposits. Aesthet Surg J 2007;27(2):146-9
   Google Scholar
• Hasengschwandtner F. Injection lipolysis for effective reduction of localized fat in place of minor surgical lipoplasty. Aesthet Surg J 2006;26(2):125-30
   Google Scholar
• Parnham MJ, Wendel A. Phospholipids and liposomes-safety for cosmetic and pharmaceutical use. Natterman Phospholipid GmbH Scientific Publication #1995432003, 2 Natterman International GmbH; Cologne, Germany: 1990
   Google Scholar
• FDA Warning Letters for Drugs Promoted in Fat Elimination Procedure from April 2010. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2010/ucm207453.htm [Last accessed 30 January 2015]
   Google Scholar
• Kythera Newsroom. Available from: http://www.kytherabiopharma.com/newsroom/article/kythera-biopharmaceuticals-announces-fda-acceptance-of-atx-101-n [Last accessed 30 January 2015]
   Google Scholar
• American Society of Plastic Surgeons. Top five cosmetic minimally-invasive procedures of 2013. Available from: www.plasticsurgery.org/news/plastic-surgery-statistics/2013/top-five-cosmetic-minimally-invasive-procedures.html [Last accessed 21 December 2014]
   Google Scholar